Join CBSET at the MGH World Medical Innovation Forum on Gene and Cell Therapies, May 2-4, 2022 at the Westin Copley Place, Boston, MA.
The World Medical Innovation Forum brings together Mass General Brigham and presenting sponsor Bank of America to advance patient benefiting technologies and including review of The Disruptive Dozen–the twelve most disruptive technologies most likely to have significant impact on gene and cell therapy in the next 18 months. The 2022 agenda features more than 200 CEOs, industry, investment and government senior leaders from across the Gene and Cell Therapy ecosystem including dozens of Harvard faculty.
CBSET's Michael Naimark presents on Cell Therapy Regulation
Related Publications:
World Pharma Today: Stem Cell and Regenerative Therapies for Hearing Loss
by Michael Naimark, MS, Director of Business Development at CBSET, Inc. and Marie-Pierre Pasdelou, PharmD, Founder and Chief Development Officer at CILcare
by Michael Naimark, MS, Director of Business Development at CBSET, Inc.